GENova appoints Dr. Philip Gould to Scientific Advi...(d commercial licensing of novel therapeu...),Health
Navigation Links
GENova appoints Dr. Philip Gould to Scientific Advisory Board
Date:9/13/2009
d commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these patented drug product candidates to Big Pharmaceutical and Biotechnology companies such as Pfizer (NYSE: PFE), Amgen (Nasdaq: AMGN), Myriad Genetics (Nasdaq: MYGN), Medarex (Nasdaq: MEDX), and Biogen Idec (Nasdaq: BIIB) . Visit GENova online at www.genovabio.com
Forward Looking Statements
This document includes certain statements that may be deemed to be "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are expected by the Company to be forward-looking statements. Although GENova believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include but are not limited to the success of the o
'/>"/>
| SOURCE GENova Biotherapeutics, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. GENova names Aaron Whiteman as CEO
2. GENova names Dr. John Savin as Vice President
3. Genova files patent for new prostate cancer treatment
4. GENova appoints Dr. Anders Boegh Jensen to Scientific Advisory Board
5. GENova discusses development of new anti-cancer biotechs potentially worth $400 Million per annum
6. GENova appoints Director of Asian business development
7. GENova files patent for new breast cancer treatment
8. GENova to acquire three new drug target patents worth in excess of $1 billion in royalty fees
9. GENova issues clarifying press release
10. WorldHeart Appoints David Pellone Chief Financial Officer
11. Novo Nordisk Appoints New Leader of North American Business
Post Your Comments:
(Date:11/25/2009)...INA,Minn.,Nov.25/PRNewswire-USNewswire/--Whenmostp...achiropractorcanalsogivepatientsthehelptheyneed.TM...yourjaw(mandible)contacts/connectswithyourskull(te...withTMJdysfunctionarepainwithchewing,clickingorpop...Jdysfunctionincluding:headaches,fatigue,sleepdistu...
(Date:11/25/2009)...NGBEACH,Calif.,Nov.25/PRNewswire/--Thanksgivingmea...orsinthegreaterLongBeachareathankstoFaithInAction/...enceatHome(IAH),adivisionofSCANHealthPlan.Formoret...volunteerstodeliverwarmThanksgivingmealstoseniorsi...hLosAngelesandsurroundingcities. ,, "Ourwarmhol...
(Date:11/25/2009)...m survivors of testicular cancer who were treated ...side effects, including neurological side effects ...treated with chemotherapy, according to a new stud...the National Cancer Institute . , Marianne Brydy...niversity Hospital, in Bergen, Norway, and colleag...
(Date:11/25/2009)... already used to fight rheumatoid arthritis, could... , WEDNESDAY, Nov. 25 (HealthDay News) -- A ... and rheumatoid arthritis now also shows some prom...1 diabetes. , The drug, rituximab (Rituxan), he...ulin, even though the disease had destroyed some o...
(Date:11/25/2009)...WYORK,Nov.25/PRNewswire/-- MISSIONSkincare ®i...nforSt.Jude.AspartofGNC,sannualSt.Jude ThanksandGi...NSkincare,s new SUPER-C(TM)LipBalm willbedonated...itytomakea$1,$5or$10donationatcheckoutatoneoftheir...rethan$1millionforSt.Judeduringtheir2009 Thanksand...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2[1] TMJ and Chiropractic Care: An Overall Wellness Approach[0] SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors[0] News brief: Long-term testicular cancer survivors at high risk for neurological side effects[1] Type 1 Diabetes May Have a New Foe[2] MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R)
...panish . , A researcher from the Physical Anthrop... has developed the most complete database today to...tes of decomposition using 3D computerised techniq...xpensive, unnecessary DNA test since facial recons...
... Regional Medical,Foundation has been awarded a th...phy (CT) services as the result of a recent survey...oud of the detailed, concerted effort our team mad..., board,certified radiologist at Sutter Regional M...
...French . , Researchers from EPFL and Caltech hav...ow humans learn to predict risk. The research, ap...uroscience, will shed light on why certain kinds o...by an erroneous evaluation of risk. , Planning e...
...lder brothers and sisters can be tough work, as an...h from a biologist at the University of North Caro...me birds, you should reserve any underdog sympathi...common wisdom, which holds that baby birds that ar...
... positron emission tomography (PET) and computed t...ore effective method to evaluate response to radia...ary follow-up treatments, a study by researchers a...d is now available online. , The clinical study i...
...d other initiatives are featured, DETROIT, March ... provide an inside look at how groundbreaking part...s Blue Shield of Michigan are,saving lives, improv...impact created,by hospitals, physicians and the Bl...
Other Medicine News:Health News:Body identification by facial reconstruction will cost less time and money 2Health News:Sutter Regional Medical Foundation Receives ACR Accreditation 2Health News:To bet or not to bet: How the brain learns to estimate risk 2Health News:Early bird doesn't always get worm, UNC researcher finds 2Health News:USC researchers find benefit for lymphoma patients in combined PET-CT scanning 2Health News:Partnerships Report Highlights How Blue Cross Blue Shield of Michigan, Physicians and Hospitals Are Working to Save Lives, Improve Care, Reduce Costs 2Health News:Partnerships Report Highlights How Blue Cross Blue Shield of Michigan, Physicians and Hospitals Are Working to Save Lives, Improve Care, Reduce Costs 3Health News:Partnerships Report Highlights How Blue Cross Blue Shield of Michigan, Physicians and Hospitals Are Working to Save Lives, Improve Care, Reduce Costs 4Body identification by facial reconstruction will cost less time and moneySutter Regional Medical Foundation Receives ACR AccreditationTo bet or not to bet: How the brain learns to estimate riskEarly bird doesn't always get worm, UNC researcher findsUSC researchers find benefit for lymphoma patients in combined PET-CT scanningPartnerships Report Highlights How Blue Cross Blue Shield of Michigan, Physicians and Hospitals Are Working to Save Lives, Improve Care, Reduce Costs
(Date:11/25/2009)...herlandsandJOHANNESBURG,November25/PRNewswire/--,i...veryannouncedtoday,thattheyhavesignedacollaborativ..., Pyxis,sworldclasscomputationalchemistryandl...rvicedivisiontoprovidemedicinaland,syntheticchemis...ationalclientnetwork.iThembaPharmaceuticalsandPyxi...
(Date:11/24/2009)...,Nov.24/PRNewswire-Asia/--ChindexInternational,Inc...ericanproviderofWestern,healthcareproductsandservi...ttheCompanywillattendthe21stAnnualPiperJaffray,"Un...009,atthe,NewYorkPalaceHotel. , Managementisc...cember1,2009,andholdone-on-onemeetingsthroughoutth...
(Date:11/24/2009)...,Nov.24/PRNewswire-FirstCall/--QuestDiagnosticsInc...iagnostictesting,informationandservices,announcedt...HealthcareConferenceinNewYorkCity.Thepresentationi...ternTime. ,, Duringtheconference,thecompanywill...te3%,operatingincometoexceed18%ofrevenues,anddilut...
Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2Chindex International to Present at Piper Jaffray Health Care Conference 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Detroit Clinic Owner and Manager Plead Guilty to Medicare Fraud Charges 58316 1Detroit Clinic Owner and Manager Plead Guilty to Medicare Fraud Charges 58316 2Detroit Clinic Owner and Manager Plead Guilty to Medicare Fraud Charges 58316 3Oklahoma Medics Embracing iB Web Service 58311 1Oklahoma Medics Embracing iB Web Service 58311 2Oncolytics Biotech 28R 29 Inc Announces Reovirus and Cisplatin Research Supports U S Phase 2 Metastatic Melanoma Trial 14269 1Oncolytics Biotech 28R 29 Inc Announces Reovirus and Cisplatin Research Supports U S Phase 2 Metastatic Melanoma Trial 14269 2...lif., Sept. 26 IDM Pharma, Inc.,(Nasdaq: IDMI ) ...f the,Committee for Medicinal Products for Human U...s Agency (EMEA) on September 25th, following the,C...Company,s Marketing,Authorization Application (MAA...patients with non-metastatic, resectable osteosarc...
...herapists Offer Tips on Preventing Possibly Life-T...A, Va., Sept. 25 The American,Physical Therapy As...on" by,Acting Surgeon General Steven K Galson, MD,...rombosis and pulmonary embolism in the United Stat...te professor of physical,therapy at Regis Universi...
Other Medicine Technology:IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 2IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 3IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 4IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 5APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism 2APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |